Humana Inc banner

Humana Inc
NYSE:HUM

Watchlist Manager
Humana Inc Logo
Humana Inc
NYSE:HUM
Watchlist
Price: 182.5 USD -2.55% Market Closed
Market Cap: $21.9B

Relative Value

The Relative Value of one HUM stock under the Base Case scenario is hidden USD. Compared to the current market price of 182.5 USD, Humana Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HUM Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

Multiples Across Competitors

HUM Competitors Multiples
Humana Inc Competitors

All Multiples
P/S
P/E
P/B
All Countries
Close
Market Cap P/S P/E P/B
US
Humana Inc
NYSE:HUM
22.1B USD 0.2 18.5 1.2
US
UnitedHealth Group Inc
NYSE:UNH
262B USD 0.6 21.7 2.6
US
Anthem Inc
LSE:0HG8
73.6B USD 0.4 13 1.7
US
Elevance Health Inc
NYSE:ELV
63.3B USD 0.3 11.2 1.4
US
Centene Corp
NYSE:CNC
21.7B USD 0.1 -3.2 1.1
US
Molina Healthcare Inc
NYSE:MOH
7.4B USD 0.2 15.7 1.8
US
Healthequity Inc
NASDAQ:HQY
6.7B USD 5.3 35.9 3.2
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.5 1.3
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 1.1 25.2 2.9
BR
Odontoprev SA
BOVESPA:ODPV3
7.3B BRL 3.1 12.8 5.7
US
Clover Health Investments Corp
NASDAQ:CLOV
1B USD 0.6 -17.5 3
P/E Multiple
Earnings Growth PEG
US
Humana Inc
NYSE:HUM
Average P/E: 18.1
18.5
51%
0.4
US
UnitedHealth Group Inc
NYSE:UNH
21.7
21%
1
US
A
Anthem Inc
LSE:0HG8
13
10%
1.3
US
Elevance Health Inc
NYSE:ELV
11.2
10%
1.1
US
Centene Corp
NYSE:CNC
Negative Multiple: -3.2 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
15.7
39%
0.4
US
Healthequity Inc
NASDAQ:HQY
35.9
68%
0.5
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
25.2
53%
0.5
BR
Odontoprev SA
BOVESPA:ODPV3
12.8
5%
2.6
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -17.5 N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett